DL
David P Luci
President and CEODirector

David P Luci insider trades: Acurx Pharmaceuticals (ACXP) stock buys and sales

President and CEO, Acurx Pharmaceuticals Last trade Jan 6, 2025 24 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2006
9
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where David reports to the SEC

and 3 more companies

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 6, 2025ACXP↑ Buy$50K
Jul 27, 2022ACXP↑ Buy$75K
Nov 19, 2021ACXP↑ Buy$25K
Mar 18, 2014DPRX↑ Buy$25K
Dec 31, 2007MACM.OB↑ Buy$2K
Mar 6, 2006AMEX:↓ Sell$1.1M
Feb 28, 2006AMEX:↓ Sell$557K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About David P Luci's insider trades

David P Luci is President and CEO at Acurx Pharmaceuticals (ACXP). Since Feb 28, 2006, David has reported 5 open-market purchases worth $177K and 2 sales worth $1.6M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (15 filings), other transactions (4 filings), option exercises (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACXP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.